We further performed stratified analysis to determine the association between LEP/LEPR polymorphisms and breast cancer risk according to obesity indicators including BMI and WHR (Table 4 and Supplementary Tables 3, 4). The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.